UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bortezomib‐based four‐drug induction does induce a response in advanced relapsed ALL but cure remains elusive

Pediatric blood & cancer, 2020-03, Vol.67 (3), p.e28115-n/a

2020

Volltextzugriff (PDF)

Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study

Blood, 2017-04, Vol.129 (14), p.1919-1926

2017

Volltextzugriff (PDF)

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1

Journal of clinical oncology, 2017-05, Vol.35 (15), p.1730-1736

2017

Volltextzugriff (PDF)

Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium

Pediatric blood & cancer, 2010-08, Vol.55 (2), p.254-259

2010

Volltextzugriff (PDF)

Allopurinol to Prevent Mercaptopurine Adverse Effects in Children and Young Adults With Acute Lymphoblastic Leukemia

Journal of pediatric hematology/oncology, 2021-04, Vol.43 (3), p.95-100

2021

Volltextzugriff (PDF)

A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium

Journal of pediatric hematology/oncology, 2014-08, Vol.36 (6), p.458-463

2014

Volltextzugriff (PDF)

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study

Pediatric blood & cancer, 2010-09, Vol.55 (3), p.421-429

2010

Volltextzugriff (PDF)

Comparison of Neurocognitive Functioning in Children Previously Randomly Assigned to Intrathecal Methotrexate Compared With Triple Intrathecal Therapy for the Treatment of Childhood Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5986-5992

2009

Volltextzugriff (PDF)

Methotrexate Polyglutamate Values in Children and Adolescents With Acute Lymphoblastic Leukemia During Maintenance Therapy

Journal of pediatric hematology/oncology, 2019-08, Vol.41 (6), p.429-432

2019

Volltextzugriff (PDF)

Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly

Pediatric blood & cancer, 2012-09, Vol.59 (3), p.436-439

2012

Volltextzugriff (PDF)

Prolonged Response in Patient With Multiply Relapsed B-cell Acute Lymphoblastic Leukemia and Monosomy-7 to Bortezomib, Lenalidomide, and Dexamethasone

Journal of pediatric hematology/oncology, 2016-08, Vol.38 (6), p.467-469

2016

Volltextzugriff (PDF)

The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia

Pediatric blood & cancer, 2014-06, Vol.61 (6), p.1003-1006

2014

Volltextzugriff (PDF)

6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children’s Oncology Group study

Blood, 2014-10, Vol.124 (15), p.2345-2353

2014

Volltextzugriff (PDF)

Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia

Journal of pediatric hematology/oncology, 2019-08, Vol.41 (6), p.457-462

2019

Volltextzugriff (PDF)

Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: A collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942)

Pediatric Blood & Cancer, 2007-09, Vol.49 (3), p.250-255

2007

Volltextzugriff (PDF)

Characteristics of patients with TEL-AML1-positive acute lymphoblastic leukemia with single or multiple fusions

Pediatric Blood & Cancer, 2007-05, Vol.48 (5), p.510-514

2007

Volltextzugriff (PDF)

Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

JAMA oncology, 2015-06, Vol.1 (3), p.287

2015

Volltextzugriff (PDF)

Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group study CCG 1922

Pediatric Blood & Cancer, 2005-07, Vol.45 (1), p.5-9

2005

Volltextzugriff (PDF)

A phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia

Journal of pediatric hematology/oncology, 2009-12, Vol.31 (12), p.936-941

2009

Volltextzugriff (PDF)

Safety and efficacy of metformin for therapy-induced hyperglycemia in children with acute lymphoblastic leukemia

Journal of pediatric hematology/oncology, 2013-10, Vol.35 (7), p.504-508

2013

Volltextzugriff (PDF)

Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia-Comparison among Different Treatment Strategies

Pediatric blood & cancer, 2016-02, Vol.63 (2), p.255-261

2016

Volltextzugriff (PDF)

Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: A report from the Children's Oncology Group

Pediatric blood & cancer, 2015-06, Vol.62 (6), p.1035-1041

2015

Volltextzugriff (PDF)

Clinical Significance of Deletions of Chromosome Arm 6q in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Cancer Group

Leukemia & lymphoma, 2000, Vol.36 (5-6), p.467-478

2000

Volltextzugriff (PDF)

Plasma pharmacokinetics of high-dose oral busulfan in children and adults undergoing bone marrow transplantation

Pediatric transplantation, 2003-01, Vol.7 (s3), p.12-18

2003

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

ThemaChild

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Humans
(37)
Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Child, Preschool
(27)
Male
(27)
Female
(25)
Hematology
(25)
Oncology
(25)
Pediatrics
(22)
Infant
(18)
Adolescent
(17)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(17)
Adult
(10)
Treatment Outcome
(10)
Prognosis
(9)
Young Adult
(9)
Acute Lymphoblastic Leukemia
(8)
Antimetabolites, Antineoplastic - Administration & Dosage
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bortezomib‐based four‐drug induction does induce a response in advanced relapsed ALL but cure remains elusive

Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1

Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium

Allopurinol to Prevent Mercaptopurine Adverse Effects in Children and Young Adults With Acute Lymphoblastic Leukemia

A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study

Comparison of Neurocognitive Functioning in Children Previously Randomly Assigned to Intrathecal Methotrexate Compared With Triple Intrathecal Therapy for the Treatment of Childhood Acute Lymphoblastic Leukemia

Methotrexate Polyglutamate Values in Children and Adolescents With Acute Lymphoblastic Leukemia During Maintenance Therapy

Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly

Prolonged Response in Patient With Multiply Relapsed B-cell Acute Lymphoblastic Leukemia and Monosomy-7 to Bortezomib, Lenalidomide, and Dexamethasone

The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia

6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children’s Oncology Group study

Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia

Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: A collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942)

Characteristics of patients with TEL-AML1-positive acute lymphoblastic leukemia with single or multiple fusions

DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysis

Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group study CCG 1922

A phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia

Safety and efficacy of metformin for therapy-induced hyperglycemia in children with acute lymphoblastic leukemia

Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia-Comparison among Different Treatment Strategies

Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: A report from the Children's Oncology Group

Clinical Significance of Deletions of Chromosome Arm 6q in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Cancer Group

Plasma pharmacokinetics of high-dose oral busulfan in children and adults undergoing bone marrow transplantation

Aktive Filter

Suchergebnisse filtern